Assessing the Differential Methylation Analysis Quality for Microarray and NGS Platforms

Anna Budkina1, Yulia A Medvedeva1,2, Alexey Stupnikov1

  • 1Department of Biomedical Physics, Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.

Summary

Microarray methods show more reliable differential methylation (DM) results than next-generation sequencing (NGS) approaches. A new metric, Hobotnica, helps evaluate DM signatures when gold standard data is unavailable.